Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E 2nd St
Ste 302
Reno, NV 89502Phone+1 775-784-1223
Education & Training
- West Virginia UniversityFellowship, Cardiovascular Disease, 1995 - 1998
- West Virginia UniversityResidency, Internal Medicine, 1992 - 1995
- New York Medical College (Brooklyn-Queens)Internship, Internal Medicine, 1991 - 1992
- J.J.M. Medical CollegeClass of 1987
Certifications & Licensure
- NV State Medical License 2007 - 2025
- LA State Medical License 2004 - 2020
- MS State Medical License 2001 - 2020
- WV State Medical License 1996 - 2003
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 11 citationsElectrocardiographic effects of intravenous cocaine: an experimental study in a canine model.Anurag Mehta, Abnash C. Jain, Mahaveer C. Mehta
Journal of Cardiovascular Pharmacology. 2003-01-01 - 22 citationsMitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus.John P. Hakim, Anurag Mehta, Abnash C. Jain, Gordon F. Murray
Texas Heart Institute Journal. 2001-01-01 - 23 citationsUsefulness of left atrial abnormality for predicting left ventricular hypertrophy in the presence of left bundle branch blockAnurag Mehta, Abnash C. Jain, Mahaveer C. Mehta, Mike Billie
The American Journal of Cardiology. 2000-02-01
Abstracts/Posters
- [Board 394] Sex-Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Its Impact on the Prognostic Significance of suPAR ...Anurag Mehta, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- Audience ARS Question: Top 3 Presentations in Diabetes/Cardiometabolic Disorders Most Likely to Impact or Change Clinical Practice or Future Research Agenda2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- My ASCVD Patient's LDL-C is 80 mg/dL. Should I Use A PCSK9 Inhibitor?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Authored Content
- Older Adults and Hypertension: Beyond the 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsFebruary 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: